Ochi Takahiro, Fujiki Ryoji, Fukuyo Masaki, Rahmutulla Bahityar, Nakagawa Takuya, Ota Masayuki, Ikeda Jun-Ichiro, Matsui Yukiko, Yoshino Ichiro, Suzuki Hidemi, Kaneda Atsushi
Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Department of Molecular Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Cancer Sci. 2025 Jul;116(7):2040-2046. doi: 10.1111/cas.70080. Epub 2025 Apr 11.
The relationship between cancer prognosis and intratumoral microbiome has recently gained attention. Regarding lung cancer, most studies have focused on bacteria outside tumors, such as sputum or lavage fluid, with few examining intratumoral bacteria and their impact on prognosis. In this study, we extracted DNA from lung tumor samples of 507 patients undergoing surgery at Chiba University Hospital and quantified intratumoral bacterial abundance using bacteria-specific PCR primers. Bacteria were detected in 77.1% of cases, and bacterial abundance was significantly higher in lung adenocarcinoma than in squamous cell carcinoma. Patients were categorized into three groups (High, Low, and Very-Low) based on bacterial abundance, and associations with clinicopathological factors were analyzed. In lung squamous cell carcinoma, higher bacterial abundance was significantly associated with worse recurrent-free survival and overall survival and was found to be a poor prognostic factor independent of pathological tumor stage. In conclusion, intratumoral bacterial abundance was found in the majority of lung cancer tissues, with variations based on pathology. This abundance may serve as a useful marker for stratifying lung squamous cell carcinoma with distinct prognoses.
癌症预后与肿瘤内微生物群之间的关系最近受到了关注。关于肺癌,大多数研究集中在肿瘤外的细菌,如痰液或灌洗液中的细菌,很少有研究检查肿瘤内细菌及其对预后的影响。在本研究中,我们从千叶大学医院接受手术的507例患者的肺肿瘤样本中提取DNA,并使用细菌特异性PCR引物对肿瘤内细菌丰度进行定量。77.1%的病例检测到细菌,肺腺癌中的细菌丰度显著高于鳞状细胞癌。根据细菌丰度将患者分为三组(高、低和极低),并分析其与临床病理因素的关联。在肺鳞状细胞癌中,较高的细菌丰度与较差的无复发生存率和总生存率显著相关,并且被发现是一个独立于病理肿瘤分期的不良预后因素。总之,在大多数肺癌组织中发现了肿瘤内细菌丰度,且因病理类型而异。这种丰度可能作为一个有用的标志物,用于对具有不同预后的肺鳞状细胞癌进行分层。